Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy

Sponsor
Marshall University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05617807
Collaborator
Arthrex, Inc. (Industry), Medstar Washington Hospital Center (Other)
100
1
2
2
49.1

Study Details

Study Description

Brief Summary

Standard arthroscopy has been the gold standard for treatment of meniscus tears since the 1980's. The purpose of this study is to analyze the clinical outcomes of using the smaller diameter Nanoscope for partial menisectomy. The authors hypothesize that the Nanoscopic partial menisectomy patients will have less pain and return function faster than standard arthroscopy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Nanoscopic partial meniscectomy
  • Procedure: Standard Partial Meniscectomy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized Controlled TrialRandomized Controlled Trial
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy
Anticipated Study Start Date :
Dec 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Feb 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nanoscopic Partial Meniscectomy

This is the experimental group. patients will have a partial meniscectomy performed using the arthrex nanoscope

Procedure: Nanoscopic partial meniscectomy
Patients will have a partial meniscectomy performed using the arthrex nanoscope and it will be compared to partial meniscectomy performed using standard arthroscopic equipment

Active Comparator: Standard Partial Meniscectomy

Patients will have a partial meniscectomy performed using standard arthroscopic equipment which is the current gold standard

Procedure: Standard Partial Meniscectomy
Patients will have partial meniscectomy performed using standard arthroscopic equipment

Outcome Measures

Primary Outcome Measures

  1. Functional Outcomes following partial meniscectomy: Knee Injury and Osteoarthritis Score [6 weeks]

    We will be looking at functional outcomes following partial meniscectomy with the nanoscope compared to standard arthroscopy by looking at Knee Injury and Osteoarthritis Score (O -100 with higher being patients doing better functionally)

  2. Functional Outcomes Following Partial Meniscectomy: International Knee Documentation Committee Score [6 weeks]

    We will be looking at functional outcomes following partial meniscectomy with the nanoscope compared to standard arthroscopy by looking at the International Knee Documentation Committee Score (0-100 with higher being patients doing better functionally)

Secondary Outcome Measures

  1. Pain: Visual Analog Pain Score [6 weeks]

    Pain following partial meniscectomy with the nanoscope compared to standard arthroscopy using Visual Analog Pain Score (0-10 with 0 being no pain and 10 being the worst pain)

  2. Narcotic Medication Use [24 hours]

    we will be looking at the amount of narcotic pain medication used following nanoscopic partial meniscectomy compared to standard arthroscopy

  3. Return to work [6 weeks]

    time to return to work following partial meniscectomy

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • MRI positive for meniscus tear

  • More than 3mm of joint space on PA flexion weightbearing x rays

  • Primary arthroscopy

Exclusion Criteria:
  • Workers compensation

  • Older than 60 years of age

  • Revision surgeries

Contacts and Locations

Locations

Site City State Country Postal Code
1 Marshall Orthopaedics - Teays Valley Scott Depot West Virginia United States 25560

Sponsors and Collaborators

  • Marshall University
  • Arthrex, Inc.
  • Medstar Washington Hospital Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shane Taylor, Principal Investigator, Marshall University
ClinicalTrials.gov Identifier:
NCT05617807
Other Study ID Numbers:
  • 1926751-2
First Posted:
Nov 16, 2022
Last Update Posted:
Nov 23, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by Shane Taylor, Principal Investigator, Marshall University

Study Results

No Results Posted as of Nov 23, 2022